Open AccessSwitching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study
Author(s) -
Kosuke Sato,
Jun Inoue,
Takehiro Akahane,
Tatsuya Kobayashi,
Shuichi Sato,
Norihiro Kisara,
Masashi Ninomiya,
Takashi Iwata,
Akitoshi Sano,
Mio Tsuruoka,
Masazumi Onuki,
Atsushi Masamune
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030630
Subject(s) - medicine , entecavir , tenofovir alafenamide , tenofovir , chronic hepatitis , hepatitis b , gastroenterology , virology , lamivudine , antiretroviral therapy , viral load , human immunodeficiency virus (hiv) , virus